A Novel Strategy to Develop Drugs That Act As Molecular Glues
Once a molecule (often a protein) is implicated in disease, the drug-development process begins—and that typically means chemists designing small-molecule drugs that bind the protein and alter its activity. But some disease-related proteins are kind of slippery – they lack obvious binding pockets or have surfaces that are difficult for small molecules to engage, making [...]